NORAMEDA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 19,145,897 | 20,939,592 | 22,991,892 | 25,750,232 | 26,380,723 | 28,371,506 | 31,277,321 | 36,437,932 |
| Profit before tax | 453,744 | 1,157,411 | 2,224,957 | 1,899,273 | 463,681 | 1,060,633 | 1,044,077 | 425,608 |
| Net profit | 305,753 | 919,481 | 1,843,676 | 1,574,443 | 328,280 | 828,773 | 828,985 | 292,991 |
| Equity | 2,901,398 | 3,820,879 | 5,464,555 | 6,438,997 | 6,170,576 | 6,399,349 | 6,628,334 | 6,321,325 |
| Liabilities | 7,127,197 | 7,145,264 | 5,075,207 | 5,700,758 | 6,407,660 | 6,381,547 | 7,521,144 | 10,350,499 |
| Non-current assets | 1,471,903 | 1,579,428 | 1,347,786 | 1,483,256 | 1,301,454 | 1,161,379 | 1,024,516 | 1,245,901 |
| Current assets | 8,582,514 | 9,426,798 | 9,248,367 | 10,868,669 | 11,458,152 | 11,469,246 | 13,093,624 | 15,499,119 |
| Total assets | 10,054,417 | 11,006,226 | 10,596,153 | 12,351,925 | 12,759,606 | 12,630,625 | 14,118,140 | 16,745,020 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,336,954 | 1,372,959 | 1,416,139 |
| Social insurance contributions | - | - | - | - | - | 501,219 | 528,320 | 563,594 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +7.4% | +9.4% | +9.8% | +12.0% | +2.4% | +7.5% | +10.2% | +16.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.0% | 8.4% | 17.4% | 12.7% | 2.6% | 6.6% | 5.9% | 1.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.5% | 24.1% | 33.7% | 24.5% | 5.3% | 13.0% | 12.5% | 4.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.6% | 4.4% | 8.0% | 6.1% | 1.2% | 2.9% | 2.7% | 0.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.4% | 5.5% | 9.7% | 7.4% | 1.8% | 3.7% | 3.3% | 1.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.5 | 1.9 | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 | 1.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 622,631 | 645,951 | 669,667 | 735,721 | 768,371 | 795,462 | 889,402 | 1,041,084 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
NORAMEDA - Social security debts
The company had no debts to Sodra
NORAMEDA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.